^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    SafeSEQ HNSCC assay

    Company:
    Sysmex Corp
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    2years
    Sysmex Inostics introduces CLIA-validated highly sensitive HNSCC-SEQ testing services for head and neck cancer at the 2022 Molecular Medicine Tri-Conference (Sysmex Press Release)
    "Sysmex Inostics...will introduce HNSCC-SEQ, a highly sensitive Plasma-Safe-SeqS and Next Generation Sequencing (NGS) assay service for head and neck squamous cell carcinomas (HNSCC), at the annual 2022 Molecular Medicine Tri-Conference being held Monday, February 21st through Wednesday, February 23rd in San Diego, California. The assay has a turn-around-time of 7-10 days and is available to researchers and clinicians."
    Launch
    |
    SafeSEQ HNSCC assay